UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Cellivery sure to win licensing deal with top pharma company
“A global pharmaceutical company is conducting a verification test on thera...
by Jeong Sae-im
|
2020-05-07 11:27
라인
Theragen Bio starts as independent company
Theragen Bio, a spin-off firm of Theragen Etex, officially launched on Mond...
by Shim Hyun-tai
|
2020-05-06 17:24
라인
Kolon begins testing gene therapy for neuropathic pain in US
Kolon Life Science said Monday it has started the administration of an expe...
by Jeong Sae-im
|
2020-04-27 16:18
라인
Pharmicell’s sales to rise with commercial supply of mPEG
Pharmicell said Friday that it has made the first shipments according to th...
by Shim Hyun-tai
|
2020-04-24 18:10
라인
Herzuma wins 40% of market share in Japan
Celltrion HealthCare said Monday that its biosimilar Herzuma (Ingredient: t...
by Shim Hyun-tai
|
2020-04-21 16:42
라인
‘Stem cell therapy more effective on Covid-19’
“I don’t know why people pay attention only to vaccines and treatments agai...
by Jeong Sae-im
|
2020-04-21 11:01
라인
‘Natural Killer cells predict immunotherapy’s efficacy in lung cancer patients’
Local researchers said the number of natural killer cells and their high ac...
by Jeong Sae-im
|
2020-04-17 16:07
라인
Samsung Bioepis launches anticancer biosimilar in US
Samsung Bioepis said Thursday that it has launched Ontruzant (Ingredient: t...
by Shim Hyun-tai
|
2020-04-16 17:32
라인
What are the odds for successful Invossa trials in US?
Pharmaceutical industry observers are closely following whether Kolon Life ...
by Jeong Sae-im
|
2020-04-14 15:01
라인
Celltrion gets antibody candidates neutralizing new coronavirus
Celltrion said Monday that it has succeeded in securing the final antibody ...
by Shim Hyun-tai
|
2020-04-13 18:16
라인
FDA OKs resumption of phase-3 Invossa trial in US
Kolon Life Science said the U.S. Food and Drug Administration has allowed t...
by Jeong Sae-im
|
2020-04-13 11:58
라인
Samsung signs contract with Vir to make COVID-19 treatment
Samsung Biologics said Friday that it has signed a letter of intent with Vi...
by Shim Hyun-tai
|
2020-04-10 18:07
라인
No Korean firms have entered trials to test COVID-19 drug candidates
Korean pharmaceutical and biotech companies have jumped in developing treat...
by Jeong Sae-im
|
2020-04-08 16:15
라인
Samsung Biologics signs CDO contract with PharmAbcine
Samsung Biologics said Monday that it has signed a contract developing orga...
by Shim Hyun-tai
|
2020-04-06 18:00
라인
AbClon draws many new human antibodies to fight COVID-19
AbClon, a company specializing in developing antibodies, said Monday that i...
by Shim Hyun-tai
|
2020-03-30 17:47
라인
ImmuneMed under fire for inflating drug’s effect against COVID-19
ImmuneMed, a local biotech firm, has come under criticism for exaggerating ...
by Jeong Sae-im
|
2020-03-27 11:49
라인
Warrant sought to arrest Medytox CEO for illegally making, selling Meditoxin
Prosecutors have requested a court to issue an arrest warrant for Medytox C...
by Jeong Sae-im
|
2020-03-25 14:09
라인
Will next-generation COVID-19 tests replace standard PCR checks?
Biotech companies are chasing new diagnostics to detect the new coronavirus...
by Jeong Sae-im
|
2020-03-25 11:40
라인
KoBioLabs' allergic immune disease treatment enters global clinical trial
KoBioLabs, a company specializing in the microbiome, said Monday that it ha...
by Shim Hyun-tai
|
2020-03-23 16:03
라인
Samsung Bioepis’ biosimilar breast cancer treatment scores FDA’s nod
Samsung Bioepis said Friday that the U.S. Food and Drug Administration has ...
by Lee Han-soo
|
2020-03-20 16:52
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top